Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses
- PMID: 6245831
- DOI: 10.1038/clpt.1980.96
Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses
Abstract
The kinetics of cefotaxime, a cephalosporin with an unusually broad antibacterial spectrum, were examined in humans after intravenous bolus injection, intravenous infusion every 6 hr for 14 days, and intramuscular injection every 8 hr for 10 days. Mean peak serum level after bolus injection of 500 mg was 37.9 microgram/ml; after 1 gm, 102.4 microgram/ml; and after 2 gm, 214.1 microgram/ml. The half-life (t1/2) was 1 hr for the 3 doses. Total serum clearance was the same for all doses. Overall excretion was 50% to 60%; part of the drug was excreted as the desacetyl derivative. After multiple intravenous infusion the elimination rate constants and t1/2 were the same on days 1 and 15. Assayable levels were present on all days 5 min before injection of a dose. Multiple intramuscular injections of 500 mg produced serum levels of 9.2 to 11.9 microgram/ml. The t1/2 was 0.93 hr. Mean serum levels at 8 hr ranged from 0.08 to 0.55 microgram/ml. Serum levels produced by intravenous infusion or intramuscular injection were inhibitory for most (90%) aerobic gram-positive and gram-negative organisms susceptible to cefotaxime.
Similar articles
-
Cefotaxime kinetics after multiple-dose intramuscular study in healthy volunteers.Chemotherapy. 1981;27(3):173-8. doi: 10.1159/000237974. Chemotherapy. 1981. PMID: 6262022
-
Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.J Infect Dis. 1978 May;137 Suppl:S80-S87. doi: 10.1093/infdis/137.supplement.s80. J Infect Dis. 1978. PMID: 650006
-
Pharmacokinetics of cefotaxime.Antimicrob Agents Chemother. 1979 Nov;16(5):592-7. doi: 10.1128/AAC.16.5.592. Antimicrob Agents Chemother. 1979. PMID: 526000 Free PMC article.
-
A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.Ther Drug Monit. 1981;3(2):121-8. doi: 10.1097/00007691-198102000-00002. Ther Drug Monit. 1981. PMID: 6455787 Review.
-
Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.Drugs. 1981 Dec;22(6):423-60. doi: 10.2165/00003495-198122060-00002. Drugs. 1981. PMID: 6459224 Review.
Cited by
-
The pharmacokinetics of new cephalosporins: significance in clinical practice.Bull N Y Acad Med. 1984 May;60(4):327-39. Bull N Y Acad Med. 1984. PMID: 6586250 Free PMC article. No abstract available.
-
Pharmacokinetics of ceftriaxone in humans.Antimicrob Agents Chemother. 1981 Nov;20(5):634-41. doi: 10.1128/AAC.20.5.634. Antimicrob Agents Chemother. 1981. PMID: 6275779 Free PMC article.
-
Clinical pharmacokinetics of the third generation cephalosporins.Clin Pharmacokinet. 1985 Mar-Apr;10(2):101-43. doi: 10.2165/00003088-198510020-00001. Clin Pharmacokinet. 1985. PMID: 3888488 Review.
-
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.Drugs. 1997 Mar;53(3):483-510. doi: 10.2165/00003495-199753030-00009. Drugs. 1997. PMID: 9074846 Review.
-
The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.J Pharmacokinet Biopharm. 1985 Apr;13(2):121-42. doi: 10.1007/BF01059394. J Pharmacokinet Biopharm. 1985. PMID: 4057054
MeSH terms
Substances
LinkOut - more resources
Full Text Sources